cancer immunotherapy Archives - Express Pharma

New cancer immunotherapy fails in first Roche trial

US FDA approves new Bristol Myers cancer immunotherapy

US FDA grants priority review to Roche’s Tecentriq as adjuvant treatment for non-small cell lung cancer

Roche gets US FDA approval for Tecentriq combo to treat advanced melanoma

DBT invites LoI to set up Virtual Network Centers in cancer immunology and immunotherapy

Bristol Myers says Opdivo performs well in kidney, lung cancer trials

Virtual Bio Pharma Conclave 2020 – Accelerating Biopharma Innovation | 21st April 2020